Tumor-associated macrophages (TAMs) typically exhibit an M2-like phenotype which can secrete various immune suppress factors, including IL-10, TGFβ, and proangiogenic factors, and previous research has established a link between TAMs and disease progression and poor prognosis of NSCLC patients (56, 57). This evidence concerns the gene IL10 and non-small cell lung carcinoma.